David Brennan - AstraZeneca
Total Compensation: $4.7M
Details: So much for those rumors that Brennan turned down a double-digit pay increase. The CEO's compensation bounced back from 2007's 19 percent drop, with his total 2008 salary of £2.51 million ($4.7 million) coming in at a 17 percent increase over 2007. Brennan's base salary dropped from 2007's $2 million to 1.8 million in 2008, but his bonus jumped from $2,016,000 to $2,425,000. He also received $406,000 in allowances, which included a car, relocation funds and cash for a vested performance share plan award.
AstraZeneca News:
AZ's Brennan sees "top-line" challenges ahead [1]
AstraZeneca - Top 5 layoffs of 2008 [2]
AZ nabs more uses for Seroquel XR [3]
AZ's Brennan tries to conceal Crestor glee [4]
AZ's expanded China focus pays off [5]
Links:
[1] http://www.fiercepharma.com/story/azs-brennan-sees-top-line-challenges-ahead/2008-12-23
[2] http://www.fiercepharma.com/special-reports/astrazeneca-top-5-layoffs-2008
[3] http://www.fiercepharma.com/story/az-nabs-more-uses-seroquel-xr/2008-11-13
[4] http://www.fiercepharma.com/story/azs-brennan-tries-conceal-crestor-glee/2008-11-11
[5] http://www.fiercepharma.com/story/azs-expanded-china-focus-pays/2008-06-13
[6] http://www.fiercepharma.com/special-reports/bayers-werner-wenning
[7] http://www.fiercepharma.com/special-reports/top-paychecks-big-pharma
[8] http://www.fiercepharma.com/special-reports/roches-severin-schwan-ceo-pay